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A rteriovenous malformation (AVM) is a congenital cerebrovascular disease that is believed to appear at the early embryonic stage of 3 weeks; however, evidence suggesting its dynamic nature of rapid growth, recurrence after total removal, and de novo development, despite its "congenital" nature, is increasing. 2, 7 Moyamoya disease is a chronic occlusive cerebrovascular disease with unknown etiology characterized by bilateral steno-occlusive changes in the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. 4 Although the rare association of moyamoya disease with an AVM has been documented in detail, the development of de novo AVMs in patients with moyamoya disease is extremely rare; it has been reported in only 2 pediatric cases. 3, 5 Here, we describe a 10-yearold girl with ischemic-onset moyamoya disease who underwent successful bilateral revascularization surgeries and developed acquired AVM in the occipital lobe during the 4-year follow-up period.
Case Report
A 10-year-old girl had repeated weakness in her bilateral upper extremities, was diagnosed with moyamoya disease, and was subsequently transferred to our hospital. A neurological examination showed no abnormalities, and 1.5-T MR angiography revealed steno-occlusive changes at the terminal portion of the bilateral internal carotid arteries (Fig. 1A) . No abnormality was found in the posterior circulation, including the right posterior ceDevelopment of a de novo arteriovenous malformation after bilateral revascularization surgery in a child with moyamoya disease The development of a de novo arteriovenous malformation (AVM) in patients with moyamoya disease is extremely rare. A 14-year-old girl developed an AVM in the right occipital lobe during the 4-year postoperative period following successful bilateral revascularization surgeries. She suffered a transient ischemic attack with hemodynamic compromise of the bilateral hemispheres at the age of 10 years. Results of an initial examination by 1.5-T MRI and MR angiography satisfied the diagnostic criteria of moyamoya disease but failed to detect any vascular malformation. Bilateral direct and indirect revascularization surgeries in the anterior circulation relieved her symptoms, and she underwent MRI and MR angiography follow-up every year after surgery. Serial T2-weighted MRI revealed the gradual appearance of flow voids in the right occipital lobe during the follow-up period. Magnetic resonance angiography ultimately indicated the development of an AVM 4 years after these surgeries when catheter angiography confirmed the diagnosis of an AVM in the right occipital lobe. The AVM remained asymptomatic, and the patient remained free of cerebrovascular events during the time she was observed by the authors. Acquired AVM in moyamoya disease is extremely rare, with only 3 pediatric cases including the present case being reported in the literature. The development of a de novo AVM in a postoperative patient with moyamoya disease appears to be unique, and this case may provide insight into the dynamic pathology of AVMs. rebral artery (PCA) territory on MR angiography (Fig.  1A) . Axial T2-weighted MRI showed several flow voids at the bilateral basal ganglia (Fig. 1B asterisks) , but none in the occipital lobe (Fig. 1C) . Since SPECT revealed apparent hemodynamic compromise, the patient underwent bilateral revascularization surgeries with superficial temporal artery-middle cerebral artery anastomosis with indirect pial synangiosis as previously described. 1 After the completion of superficial temporal artery-middle cerebral artery anastomosis, conventional encephalo-duromyo-synangiosis was performed at the territory of the middle cerebral artery (MCA). No additional bur holes or extended indirect bypass procedure was performed in the posterior circulation. The patient's postoperative course was uneventful, and her transient ischemic attacks completely disappeared after the surgeries. She underwent routine follow-up MR imaging/angiography every year at an outpatient clinic.
Four years postoperatively, T2-weighted imaging revealed an apparent flow void in the right occipital lobe (Fig. 1F) , and MR angiography showed an AVM in the vascular territory of the right PCA. Flow voids at the bilateral basal ganglia were partially decreased by the effect of revascularization surgeries. Catheter angiography confirmed a Spetzler-Martin Grade II AVM in the right occipital lobe. A retrospective inspection of T2-weighted images obtained 3 years postoperatively identified a flow void in the right occipital lobe (Fig. 1E arrow) . In light of a previous report indicating the efficacy of radiosurgery for AVM associated with moyamoya disease, 6 we proposed Gamma Knife radiosurgery for the de novo AVM in this patient. We introduced this patient and family to the outpatient consultation service for Gamma Knife radiosurgery, but the patient and her parents finally chose conservative observation. The patient remained asymptomatic after the surgeries; we have continued to observe the patient and have observed no cerebrovascular events for 2 years.
Discussion
We demonstrated the temporal profile of MRI findings for the development of AVM during a 4-year postoperative period after bilateral revascularization surgeries for moyamoya disease in a 14-year-old girl. The exact mechanism by which an acquired AVM developed in the vascular territory supplied by the PCA without steno-occlusive changes is unknown. In light of the absence of hemodynamic compromise in the occipital lobe, as shown by SPECT pre-and postoperatively, cerebral ischemia was not likely to be the major trigger for the development of the acquired AVM. Because we did not perform extended indirect pial synan- giosis and/or an additional bur hole technique in the posterior circulation, the initiation of AVM development could not have been due to the iatrogenic arteriovenous fistula at the initial surgery for moyamoya disease. Alternatively, based on the absence of catheter angiography at the initial onset of moyamoya disease as well as on the classic observation that AVM is a congenital disease, we do not completely rule out the possibility that the patient initially had a micro-AVM or small arteriovenous fistula before bilateral revascularization, which was not evident on MRI. From the viewpoint of basic pathology, moyamoya disease and an AVM are known to have similar biological backgrounds of the increased expression of angiogenic factors such as vascular endothelial growth factor, as well as inflammatory molecules, including tumor necrosis factor-a, interleukin-6, and matrix metalloproteinases. 4, 7 The expression of these molecules in moyamoya disease could have caused the acquired AVM to develop in the present case. Alternatively, the development of the de novo AVM in the present case may provide an insight into elucidating the dynamic pathology of AVMs.
